Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline-rich protein 20D (PRR20D) is a member of the proline-rich protein 20 family, which includes several closely related proteins (PRR20A, PRR20B, PRR20C, PRR20E). Proteins in this family are characterized by a high content of proline residues. Proline-rich motifs are known to mediate protein-protein interactions by adopting polyproline type II helical conformations, which can serve as recognition sites for cellular signaling domains (e.g., SH3, WW, and EVH1 domains)[1][2]. However, despite the biochemical relevance of proline-rich motifs within the proteome, there is currently no evidence that PRR20D itself has a well-established biological function, therapeutic relevance, or established role in human disease. PRR20D is not classified as a receptor, enzyme, transporter, or other common drug target class, and there are no known drugs or mechanisms of action specifically associated with this protein. Based on available data, PRR20D is not considered a therapeutic target, and significant information regarding its functional or clinical relevance is lacking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline-rich protein 20D (PRR20D).